PACIRA BIOSCIENCES, INC. Class of Warrant or Right, Outstanding
PACIRA BIOSCIENCES, INC. (PCRX) had Class of Warrant or Right, Outstanding of 0 shares as of 2016-12-31, per its 10-K filed 2017-03-01.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2017-03-01
- 2016-12-31: Class of Warrant or Right, Outstanding 0.00 shares.
- 2015-12-31: Class of Warrant or Right, Outstanding 7.22K shares.
- 2014-12-31: Class of Warrant or Right, Outstanding 7.22K shares.
- 2013-12-31: Class of Warrant or Right, Outstanding 58.35K shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2016-12-31 | 0.00 shares 10-K · filed 2017-03-01 |
| 2015-12-31 | 7.22K shares 10-K · filed 2017-03-01 |
| 2014-12-31 | 7.22K shares 10-K · filed 2016-02-25 |
| 2013-12-31 | 58.35K shares 10-K · filed 2015-02-24 |
| 2012-12-31 | 490.46K shares 10-K · filed 2014-02-25 |
| 2011-12-31 | 527.66K shares 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |